The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib

M. K. Vasakova,N. Mogulkoc, M. Kramer, M. Doubkova, M. Plackova, V. Mueller,M. J. Studnicka, M. Zurkova, L. Lacina, K. Lewandowska,V. Bartos, P. Ovesna, J. Gregor

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2023）

引用 0|浏览3